Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

CXCL4/PF4 is a predictive biomarker of cardiac differentiation potential of human induced pluripotent stem cells.

Ohashi F, Miyagawa S, Yasuda S, Miura T, Kuroda T, Itoh M, Kawaji H, Ito E, Yoshida S, Saito A, Sameshima T, Kawai J, Sawa Y, Sato Y.

Sci Rep. 2019 Mar 15;9(1):4638. doi: 10.1038/s41598-019-40915-w.

2.

Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.

Streckfuss-Bömeke K, Wolf F, Azizian A, Stauske M, Tiburcy M, Wagner S, Hübscher D, Dressel R, Chen S, Jende J, Wulf G, Lorenz V, Schön MP, Maier LS, Zimmermann WH, Hasenfuss G, Guan K.

Eur Heart J. 2013 Sep;34(33):2618-29. doi: 10.1093/eurheartj/ehs203. Epub 2012 Jul 12.

PMID:
22798560
3.

Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.

Altomare C, Pianezzi E, Cervio E, Bolis S, Biemmi V, Benzoni P, Camici GG, Moccetti T, Barile L, Vassalli G.

Europace. 2016 Dec;18(suppl 4):iv67-iv76. doi: 10.1093/europace/euw352.

PMID:
28011833
4.

Signature of circular RNAs in human induced pluripotent stem cells and derived cardiomyocytes.

Lei W, Feng T, Fang X, Yu Y, Yang J, Zhao ZA, Liu J, Shen Z, Deng W, Hu S.

Stem Cell Res Ther. 2018 Mar 9;9(1):56. doi: 10.1186/s13287-018-0793-5.

5.

Comparative analysis of targeted differentiation of human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells reveals variability associated with incomplete transgene silencing in retrovirally derived hiPSC lines.

Toivonen S, Ojala M, Hyysalo A, Ilmarinen T, Rajala K, Pekkanen-Mattila M, Äänismaa R, Lundin K, Palgi J, Weltner J, Trokovic R, Silvennoinen O, Skottman H, Narkilahti S, Aalto-Setälä K, Otonkoski T.

Stem Cells Transl Med. 2013 Feb;2(2):83-93. doi: 10.5966/sctm.2012-0047. Epub 2013 Jan 22.

6.

Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression.

Uosaki H, Fukushima H, Takeuchi A, Matsuoka S, Nakatsuji N, Yamanaka S, Yamashita JK.

PLoS One. 2011;6(8):e23657. doi: 10.1371/journal.pone.0023657. Epub 2011 Aug 18.

7.

Highly efficient transfection of human induced pluripotent stem cells using magnetic nanoparticles.

Yamoah MA, Moshref M, Sharma J, Chen WC, Ledford HA, Lee JH, Chavez KS, Wang W, López JE, Lieu DK, Sirish P, Zhang XD.

Int J Nanomedicine. 2018 Oct 5;13:6073-6078. doi: 10.2147/IJN.S172254. eCollection 2018.

8.

Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.

Zwi-Dantsis L, Huber I, Habib M, Winterstern A, Gepstein A, Arbel G, Gepstein L.

Eur Heart J. 2013 Jun;34(21):1575-86. doi: 10.1093/eurheartj/ehs096. Epub 2012 May 22.

PMID:
22621821
9.

Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells.

Mehta A, Chung YY, Ng A, Iskandar F, Atan S, Wei H, Dusting G, Sun W, Wong P, Shim W.

Cardiovasc Res. 2011 Sep 1;91(4):577-86. doi: 10.1093/cvr/cvr132. Epub 2011 May 12.

PMID:
21565833
10.

Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.

Wang J, Hao J, Bai D, Gu Q, Han W, Wang L, Tan Y, Li X, Xue K, Han P, Liu Z, Jia Y, Wu J, Liu L, Wang L, Li W, Liu Z, Zhou Q.

Stem Cell Res Ther. 2015 Nov 12;6:223. doi: 10.1186/s13287-015-0206-y.

11.

Ontogenic development of cardiomyocytes derived from transgene-free human induced pluripotent stem cells and its homology with human heart.

Sequiera GL, Mehta A, Ooi TH, Shim W.

Life Sci. 2013 Jan 17;92(1):63-71. doi: 10.1016/j.lfs.2012.10.020. Epub 2012 Nov 7.

PMID:
23142239
12.

Plasma-activated medium selectively eliminates undifferentiated human induced pluripotent stem cells.

Matsumoto R, Shimizu K, Nagashima T, Tanaka H, Mizuno M, Kikkawa F, Hori M, Honda H.

Regen Ther. 2016 Sep 10;5:55-63. doi: 10.1016/j.reth.2016.07.001. eCollection 2016 Dec.

13.

Effective cardiac myocyte differentiation of human induced pluripotent stem cells requires VEGF.

Ye L, Zhang S, Greder L, Dutton J, Keirstead SA, Lepley M, Zhang L, Kaufman D, Zhang J.

PLoS One. 2013;8(1):e53764. doi: 10.1371/journal.pone.0053764. Epub 2013 Jan 10.

14.

Same-Single-Cell Analysis of Pacemaker-Specific Markers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Subtypes Classified by Electrophysiology.

Yechikov S, Copaciu R, Gluck JM, Deng W, Chiamvimonvat N, Chan JW, Lieu DK.

Stem Cells. 2016 Nov;34(11):2670-2680. doi: 10.1002/stem.2466. Epub 2016 Jul 29.

15.

Electrical Stimulation Enhances Cardiac Differentiation of Human Induced Pluripotent Stem Cells for Myocardial Infarction Therapy.

Ma R, Liang J, Huang W, Guo L, Cai W, Wang L, Paul C, Yang HT, Kim HW, Wang Y.

Antioxid Redox Signal. 2018 Feb 10;28(5):371-384. doi: 10.1089/ars.2016.6766. Epub 2017 Jan 12.

16.

Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.

van den Berg CW, Elliott DA, Braam SR, Mummery CL, Davis RP.

Methods Mol Biol. 2016;1353:163-80. doi: 10.1007/7651_2014_178.

PMID:
25626427
17.

A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability.

Burridge PW, Thompson S, Millrod MA, Weinberg S, Yuan X, Peters A, Mahairaki V, Koliatsos VE, Tung L, Zambidis ET.

PLoS One. 2011 Apr 8;6(4):e18293. doi: 10.1371/journal.pone.0018293.

18.

Simple suspension culture system of human iPS cells maintaining their pluripotency for cardiac cell sheet engineering.

Haraguchi Y, Matsuura K, Shimizu T, Yamato M, Okano T.

J Tissue Eng Regen Med. 2015 Dec;9(12):1363-75. doi: 10.1002/term.1761. Epub 2013 Jun 3.

PMID:
23728860
19.

Purification of small molecule-induced cardiomyocytes from human induced pluripotent stem cells using a reporter system.

Hwang GH, Park SM, Han HJ, Kim JS, Yun SP, Ryu JM, Lee HJ, Chang W, Lee SJ, Choi JH, Choi JS, Lee MY.

J Cell Physiol. 2017 Dec;232(12):3384-3395. doi: 10.1002/jcp.25783. Epub 2017 Apr 18.

PMID:
28063225
20.

Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.

Sridhar A, Ohlemacher SK, Langer KB, Meyer JS.

Stem Cells Transl Med. 2016 Apr;5(4):417-26. doi: 10.5966/sctm.2015-0093. Epub 2016 Mar 1.

Supplemental Content

Support Center